Revolade 25 mg
Revolade 25 mg is a medicine authorised by Swissmedic under authorisation number 60122. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 23 June 2010 and the authorisation is valid without a time limit. ATC code B02BX05 places the medicine in the group Antihemorrhagics.
| Authorisation number | 60122 |
|---|---|
| Name | Revolade 25 mg |
| Full name | Revolade 25 mg, Filmtabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | B02BX05 |
| First authorisation | 23 June 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Revolade 25 mg, Filmtabletten | A | 23 June 2010 |
| 2 | Revolade 50 mg, Filmtabletten | A | 23 June 2010 |
| 5 | Revolade 12,5 mg, Filmtabletten | A | 18 September 2017 |
| 6 | Revolade 75 mg, Filmtabletten | A | 08 May 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 14 | Tablette(n) | B02BX05 | 06.99.0. | A |
| 2 | 28 | Tablette(n) | B02BX05 | 06.99.0. | A |
| 3 | 14 | Tablette(n) | B02BX05 | 06.99.0. | A |
| 4 | 28 | Tablette(n) | B02BX05 | 06.99.0. | A |
| 5 | 14 | Tablette(n) | B02BX05 | 06.99.0. | A |
| 6 | 28 | Tablette(n) | B02BX05 | 06.99.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Revolade 25 mg authorised in Switzerland?
Yes. Revolade 25 mg is authorised by Swissmedic under authorisation number 60122, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Revolade 25 mg have?
Revolade 25 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Revolade 25 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.